SCNI Scinai Immunotherapeutics Ltd. - American Depositary Shares
$0.50
Price · May 20, 2026
Fundamentals as of May 15, 2023
52W Range
$0–$6
1% of range
Analyst Rating
BUY
7 analysts
Price Target
—
P/E (TTM)
—
ROE
—
Net Profit Margin
—
SCNI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.50
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $6
SCNI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
2021-12-31
→
2022-12-31
Free Cash Flow
—
2022-12-31
→
2022-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
SCNI
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
SCNI
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
SCNI
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
SCNI
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
SCNI
Peer Median
SCNI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
7 analysts
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
3.6%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2023 | $-4.70 | $-6.32 | 1.6% |
| Sept. 30, 2023 | $8.00 | $-10.10 | 18.1% |
| June 30, 2023 | $-11.10 | $-9.28 | -1.8% |
| March 31, 2023 | $-10.90 | $-7.45 | -3.5% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| SCNI | — | — | — | — | — | — |
| CLGN | — | — | — | — | — | — |
| GLMD | — | — | — | — | — | — |
| SLXN | — | — | — | — | — | — |
| URGN | $1.13B | — | 21.4% | -139.8% | 154.4% | 88.7% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 10
| Metric | Trend | 2022 | 2021 |
|---|---|---|---|
| R&D Expense | $6M | $3M | |
| SG&A Expense | $5M | $8M | |
| Operating Income | $-11M | $-11M | |
| Other Non-op | $5M | $496.0K | |
| Net Income | $-6M | $-8M | |
| EPS (Basic) | $-0.01 | $-0.02 | |
| EPS (Diluted) | $-0.01 | $-0.02 | |
| Shares (Basic) | 754,076,407 | 564,575,967 | |
| Shares (Diluted) | 754,076,407 | 564,575,967 | |
| EBITDA | $-10M | · |
Balance Sheet 18
| Metric | Trend | 2022 | 2021 |
|---|---|---|---|
| Cash & Equivalents | $14M | $17M | |
| Prepaid Expense | $155.0K | $228.0K | |
| Current Assets | $14M | $18M | |
| PP&E (Net) | $11M | $12M | |
| PP&E (Gross) | $14M | $15M | |
| Accum. Depreciation | $2M | $2M | |
| Total Assets | $27M | $32M | |
| Accrued Liabilities | $756.0K | $361.0K | |
| Short-term Debt | $382.0K | $375.0K | |
| Current Liabilities | $2M | $2M | |
| Capital Leases | $1M | $1M | |
| Total Debt | $382.0K | · | |
| Paid-in Capital | $116M | $113M | |
| Retained Earnings | $-116M | $-110M | |
| AOCI | $-2M | $-2M | |
| Stockholders' Equity | $-2M | $982.0K | |
| Liabilities + Equity | $27M | $32M | |
| Shares Outstanding | 989,290,784 | 739,048,544 |
Cash Flow 9
| Metric | Trend | 2022 | 2021 |
|---|---|---|---|
| D&A | $562.0K | $471.0K | |
| Stock-based Comp | $2M | $3M | |
| Other Non-cash | $-4M | · | |
| Operating Cash Flow | $-7M | $-7M | |
| CapEx | $836.0K | $139.0K | |
| Investing Cash Flow | $-836.0K | $-139.0K | |
| Financing Cash Flow | $7M | $21M | |
| Net Change in Cash | $-3M | $14M | |
| Free Cash Flow | $-8M | · |
Profitability 2
| Metric | Trend | 2022 | 2021 |
|---|---|---|---|
| ROA | -19.6% | · | |
| ROE | 442.1% | · |
Liquidity & Solvency 3
| Metric | Trend | 2022 | 2021 |
|---|---|---|---|
| Current Ratio | 6.1 | · | |
| Quick Ratio | 6.0 | · | |
| Debt / Equity | -0.2 | · |
Valuation (TTM) 10
| Metric | Trend | 2022 | 2021 |
|---|---|---|---|
| Net Income TTM | $-6M | · | |
| Market Cap | $29.28B | · | |
| Enterprise Value | $29.27B | · | |
| P/E | -2960.0 | · | |
| P/B | -16638.1 | · | |
| P / Cash Flow | -4030.7 | · | |
| P / FCF | -3614.7 | · | |
| EV / EBITDA | -2787.8 | · | |
| EV / FCF | -3613.0 | · | |
| Earnings Yield | -0.03% | · |
Income Statement 10
| Metric | Trend | Q1 2023 |
|---|---|---|
| R&D Expense | $2M | |
| SG&A Expense | $1M | |
| Operating Income | $-3M | |
| Other Non-op | $-329.0K | |
| Net Income | $-4M | |
| EPS (Basic) | $-0.00 | |
| EPS (Diluted) | $-0.00 | |
| Shares (Basic) | 1,295,256,604 | |
| Shares (Diluted) | 1,295,256,604 | |
| EBITDA | $-3M |
Balance Sheet 13
| Metric | Trend | Q1 2023 |
|---|---|---|
| Cash & Equivalents | $11M | |
| Prepaid Expense | $119.0K | |
| Current Assets | $11M | |
| PP&E (Net) | $11M | |
| Total Assets | $23M | |
| Current Liabilities | $3M | |
| Capital Leases | $1M | |
| Paid-in Capital | $116M | |
| Retained Earnings | $-119M | |
| AOCI | $-2M | |
| Stockholders' Equity | $-5M | |
| Liabilities + Equity | $23M | |
| Shares Outstanding | 1,313,623,184 |
Cash Flow 8
| Metric | Trend | Q1 2023 |
|---|---|---|
| D&A | $138.0K | |
| Stock-based Comp | $252.0K | |
| Other Non-cash | $66.0K | |
| Operating Cash Flow | $-3M | |
| CapEx | $6.0K | |
| Investing Cash Flow | $-6.0K | |
| Net Change in Cash | $-3M | |
| Free Cash Flow | $-3M |
Profitability 2
| Metric | Trend | Q1 2023 |
|---|---|---|
| ROA | -30.2% | |
| ROE | 146.2% |
Liquidity & Solvency 2
| Metric | Trend | Q1 2023 |
|---|---|---|
| Current Ratio | 4.3 | |
| Quick Ratio | 4.2 |
Valuation (TTM) 4
| Metric | Trend | Q1 2023 |
|---|---|---|
| Market Cap | $28.37B | |
| P/B | -5899.0 | |
| P / Cash Flow | -9275.7 | |
| P / FCF | -9257.5 |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2022-12-31 | 2021-12-31 | |
|---|---|---|
| Net Income | $-6M | $-8M |
| Diluted EPS | $-0.01 | $-0.02 |
Balance Sheet
| 2022-12-31 | 2021-12-31 | |
|---|---|---|
| Debt / Equity | -0.2 | — |
| Current Ratio | 6.1 | — |
| Quick Ratio | 6.0 | — |
Cash Flow
| 2022-12-31 | 2021-12-31 | |
|---|---|---|
| Free Cash Flow | $-8M | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.